Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.2.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.25NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.33NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
FL.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.29NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.13NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
GP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GP.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.3.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.3.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.65.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.65.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LF.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.1.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XDVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDVNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.2.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.9NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.25 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.25.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.1 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.25.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.3 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.75 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.75 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26650.4US
JN.1.7.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
MF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MF.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22750.3US
JN.1.29.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.29.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
MG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MG.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used